Linh H. Le
Chief Financial OfficerMr. Linh H. Le serves as Chief Financial Officer of Freenome, Inc. since May 2025. He was Chief Financial Officer of Predicine, Inc. from December 2021 until March 2023. He was Chief Operating Officer of Ambry Genetics Corporation from January 12, 2018 to December 2022. He serves as Chief Financial Officer at Predicine, Inc. since December 2021. Mr. Le has more than 25 years of work experience, stemming from several industry sectors including medical devices, biopharmaceutical, entertainment and management advisory services. Mr. Le spent the last few years in the healthcare industry overseeing financial operations at Medtronic’s Diabetes Intensive Insulin Business Unit. Prior to that, Linh held leadership roles at the Walt Disney Company, PricewaterhouseCoopers, Twentieth Century Fox and KPMG. He is a Certified Public Accountant, holds a Bachelor of Science in Business Administration and Accounting from California State University, Northridge and completed executive coursework at the Wharton School of Business. He was named CFO of the Year by the Los Angeles Times in 2022.
Positions
- Company NameFreenome, Inc.Stock CodeFRNMPositionChief Financial OfficerColleagues
- AEAaron ElliottCEO & Director
- RERiley EnnisCo-Founder & Chief Product Officer
- CLCheng-Ho LinChief Scientific Officer
- TFThomas F. FitzpatrickChief Legal Officer
- RWRandal W. ScottIndependent Director
- DPDeepa PakianathanIndependent Director
- DMDouglas M. VanOortIndependent Director
- PKPeter KolchinskyIndependent Director
